Physician profile
Sandra Jimenez
NPI 1346437043
$2,118.65
in general payments reported to CMS, 2019-2025
10 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $747 · 2023: $534 · 2024: $320 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,110.19 | 2022-2025 | Yeztugo |
| Abbvie INC. | $213.88 | 2022 | |
| Viiv Healthcare Company | $125.00 | 2021 | |
| Bsn Medical INC | $117.79 | 2025 | |
| Amgen INC. | $117.75 | 2022 | |
| Janssen Products, LP | $117.64 | 2022 | |
| Merck Sharp & Dohme LLC | $96.14 | 2022 | |
| Sumitomo Pharma America, INC. | $84.96 | 2023 | Gemtesa |
| Novo Nordisk INC | $76.21 | 2022 | |
| Intra-Sana Laboratories | $59.09 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.